Mostrar el registro sencillo del ítem

dc.contributor.author
Marques Ventura, Ana Lucia  
dc.contributor.author
dos Santos Rodrigues, Alexandre  
dc.contributor.author
Mitchell, Claire H.  
dc.contributor.author
Faillace, Maria Paula  
dc.date.available
2023-09-13T14:01:04Z  
dc.date.issued
2019-09  
dc.identifier.citation
Marques Ventura, Ana Lucia; dos Santos Rodrigues, Alexandre; Mitchell, Claire H.; Faillace, Maria Paula; Purinergic signaling in the retina: From development to disease; Pergamon-Elsevier Science Ltd; Brain Research Bulletin; 151; 9-2019; 92-108  
dc.identifier.issn
0361-9230  
dc.identifier.uri
http://hdl.handle.net/11336/211362  
dc.description.abstract
Retinal injuries and diseases are major causes of human disability involving vision impairment by the progressive and permanent loss of retinal neurons. During development, assembly of this tissue entails a successive and overlapping, signal-regulated engagement of complex events that include proliferation of progenitors, neurogenesis, cell death, neurochemical differentiation and synaptogenesis. During retinal damage, several of these events are re-activated with both protective and detrimental consequences. Purines and pyrimidines, along with their metabolites are emerging as important molecules regulating both retinal development and the tissue's responses to damage. The present review provides an overview of the purinergic signaling in the developing and injured retina. Recent findings on the presence of vesicular and channel-mediated ATP release by retinal and retinal pigment epithelial cells, adenosine synthesis and release, expression of receptors and intracellular signaling pathways activated by purinergic signaling in retinal cells are reported. The pathways by which purinergic receptors modulate retinal cell proliferation, migration and death of retinal cells during development and injury are summarized. The contribution of nucleotides to the self-repair of the injured zebrafish retina is also discussed.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Pergamon-Elsevier Science Ltd  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
ATP  
dc.subject
ADENOSINE  
dc.subject
NUCLEOTIDES  
dc.subject
P1 RECEPTORS  
dc.subject
P2 RECEPTORS  
dc.subject
RETINA DISEASES  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Purinergic signaling in the retina: From development to disease  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2023-09-12T18:06:46Z  
dc.journal.volume
151  
dc.journal.pagination
92-108  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Marques Ventura, Ana Lucia. Universidade Federal Fluminense; Brasil  
dc.description.fil
Fil: dos Santos Rodrigues, Alexandre. Universidade Federal Fluminense; Brasil  
dc.description.fil
Fil: Mitchell, Claire H.. University of Pennsylvania; Estados Unidos  
dc.description.fil
Fil: Faillace, Maria Paula. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Ciencias Fisiológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina  
dc.journal.title
Brain Research Bulletin  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0361923018305379  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.brainresbull.2018.10.016